MARKET

IVC

IVC

Invacare
NYSE

Real-time Quotes | Nasdaq Last Sale

0.9008
+0.0597
+7.10%
After Hours: 0.9198 +0.019 +2.11% 19:07 05/26 EDT
OPEN
0.8500
PREV CLOSE
0.8411
HIGH
0.9500
LOW
0.8400
VOLUME
688.84K
TURNOVER
0
52 WEEK HIGH
8.83
52 WEEK LOW
0.8033
MARKET CAP
32.11M
P/E (TTM)
-0.5661
1D
5D
1M
3M
1Y
5Y
Invacare Introduces the Birdie™ Evo XPLUS Patient Lift to the U.S. Market
ELYRIA, Ohio, May 24, 2022--Invacare Corporation (NYSE: IVC) announced the U.S. introduction of its Birdie™ Evo XPLUS, an innovative patient lift solution for the post-acute care setting. With its sleek and modern design, the Birdie Evo XPLUS provides inno...
Business Wire · 2d ago
Invacare (IVC) Reports Q1 Loss, Tops Revenue Estimates
Invacare (IVC) delivered earnings and revenue surprises of -60.47% and 2.37%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/09 22:35
Invacare Q1 EPS $(0.69) Misses $(0.43) Estimate, Sales $200.99M Beat $197.46M Estimate; Reaffirms Guidance
Invacare (NYSE:IVC) reported quarterly losses of $(0.69) per share which missed the analyst consensus estimate of $(0.43) by 60.47 percent. This is a 91.67 percent decrease over losses of $(0.36) per share from the same
Benzinga · 05/09 21:30
Invacare GAAP EPS of -$0.69 misses by $0.25, revenue of $201M beats by $3.54M
Invacare press release (NYSE:IVC): Q1 GAAP EPS of -$0.69 misses by $0.25. Revenue of $201M (+2.4% Y/Y) beats by $3.54M. Company reaffirms its financial guidance for the full year 2022.
Seekingalpha · 05/09 20:52
BRIEF-Invacare Reports Results For First Quarter 2022
reuters.com · 05/09 20:46
-- Earnings Flash (IVC) INVACARE CORPORATION Posts Q1 Revenue $201M, vs. Street Est of $197.5M
MT Newswires · 05/09 16:52
Earnings Scheduled For May 9, 2022
  Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million.
Benzinga · 05/09 08:52
Cardinal Health (CAH) Q3 Earnings Miss Estimates
Cardinal (CAH) delivered earnings and revenue surprises of -5.84% and 4.26%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/05 12:15
More
No Data
Learn about the latest financial forecast of IVC. Analyze the recent business situations of Invacare through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 3 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

33.33%Strong Buy
33.33%Buy
33.33%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average IVC stock price target is 6.25 with a high estimate of 6.50 and a low estimate of 6.00.
High6.50
Average6.25
Low6.00
Current 0.9008
EPS
Actual
Estimate
-0.44-0.31-0.17-0.04
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 186
Institutional Holdings: 33.09M
% Owned: 92.84%
Shares Outstanding: 35.64M
TypeInstitutionsShares
Increased
29
3.08M
New
11
399.02K
Decreased
50
4.54M
Sold Out
24
3.24M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.53%
Healthcare Equipment & Supplies
+0.56%
Key Executives
Chairman/President/Chief Executive Officer/Director
Matthew Monaghan
Chief Financial Officer/Senior Vice President
Kathleen Leneghan
Chief Human Resource Officer/Senior Vice President
Rick Cassiday
Senior Vice President/Chief Technology Officer/Chief Information Officer
Angela Goodwin
Senior Vice President/Chief Administrative Officer/General Counsel/Secretary
Anthony LaPlaca
Senior Vice President/General Manager
Joost Beltman
Senior Vice President/General Manager
Geoffrey Purtill
Lead Director/Independent Director
C. Martin Harris
Independent Director
Susan Alexander
Independent Director
Julie Beck
Independent Director
Petra Danielsohn-Weil
Independent Director
Stephanie Fehr
Independent Director
Marc Gibeley
Independent Director
Clifford Nastas
Independent Director
Aron Schwartz
No Data
No Data
About IVC
Invacare Corporation is a multinational company that designs, manufactures and distributes durable medical devices that help people to move, breathe, rest and perform essential hygiene. The Company's segments include North America and Europe. Its North America and Europe segment selling the Company's primary product categories, which include lifestyle, mobility and seating and respiratory therapy products. The Company provides clinically complex medical device solutions for congenital, including cerebral palsy, muscular dystrophy, spina bifida, stroke, spinal cord injury, traumatic brain injury, post-acute recovery, pressure ulcers, and degenerative age-related, bariatric conditions. It sells its products principally to home medical equipment providers with retail and e-commerce channels, residential care operators, dealers and government health services in North America, Europe and the Asia Pacific.

Webull offers kinds of Invacare Corporation stock information, including NYSE:IVC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IVC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading IVC stock methods without spending real money on the virtual paper trading platform.